S&P rates Omega notes BB+

Standard & Poor's it rated Omega Healthcare Investors Inc.'s new $350 million of 6¾% senior unsecured notes due 2022 BB+ with a 2 recovery rating.

The notes, which priced at a premium to yield 6.26%, are an add-on to the company's $225 million offering that closed in October, the agency said.

Omega will use proceeds to fund the previously announced tender offer for its $310 million of 7% senior unsecured notes due 2014 and for other corporate purposes, S&P added.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.